[Congressional Bills 107th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2051 Referred in Senate (RFS)]
107th CONGRESS
2d Session
H. R. 2051
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
May 15 (legislative day, May 9), 2002
Received; read twice and referred to the Committee on Health,
Education, Labor, and Pensions
_______________________________________________________________________
AN ACT
To authorize the National Science Foundation to establish regional
centers for the purpose of plant genome and gene expression research
and development and international research partnerships for the
advancement of plant biotechnology in the developing world.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. DEFINITIONS.
In this Act--
(1) the term ``Director'' means the Director of the
National Science Foundation;
(2) the term ``institution of higher education'' has the
meaning given such term in section 101 of the Higher Education
Act of 1965 (20 U.S.C. 1001); and
(3) the term ``nonprofit organization'' means a nonprofit
research institute or a nonprofit association with experience
and capability in plant biotechnology research as determined by
the Director.
SEC. 2. MATCHING FUNDS.
The Director may establish matching fund requirements for grantees
to receive grants under this Act.
SEC. 3. PLANT GENOME AND GENE EXPRESSION RESEARCH CENTERS.
(a) In General.--The Director shall award grants to consortia of
institutions of higher education or nonprofit organizations (or both)
to establish regional plant genome and gene expression research
centers. Grants shall be awarded under this section on a merit-
reviewed, competitive basis. When making awards, the Director shall, to
the extent practicable, ensure that the program created by this section
examines as many different agricultural environments as possible.
(b) Purpose.--The purpose of the centers established pursuant to
subsection (a) shall be to conduct research in plant genomics and plant
gene expression. A center's activities may include--
(1) basic plant genomics research and genomics
applications, including those related to cultivation of crops
in extreme environments and to cultivation of crops with
reduced reliance on fertilizer;
(2) basic research that will contribute to the development
or use of innovative plant-derived products;
(3) basic research on alternative uses for plants and plant
materials, including the use of plants as renewable feedstock
for alternative energy production and nonpetroleum-based
industrial chemicals and precursors; and
(4) basic research and dissemination of information on the
ecological and other consequences of genetically engineered
plants.
SEC. 4. PARTNERSHIPS FOR PLANT BIOTECHNOLOGY IN THE DEVELOPING WORLD.
(a) In General.--(1) The Director shall award grants to
institutions of higher education, nonprofit organizations, or consortia
of such entities to establish research partnerships for supporting the
development of plant biotechnology targeted to the needs of the
developing world. The Director, by means of outreach, shall encourage
inclusion of Historically Black Colleges or Universities, Hispanic-
serving institutions, or tribal colleges or universities in consortia
that enter into such partnerships.
(2) In order to be eligible to receive a grant under this section,
an institution of higher education or eligible nonprofit organization
(or consortium thereof) shall enter into a partnership with one or more
research institutions in one or more developing nations and may also
include for-profit companies involved in plant biotechnology.
(3) Grants under this section shall be awarded on a merit-reviewed
competitive basis.
(b) Purpose.--Grants awarded under this section shall be used for
support of research in plant biotechnology targeted to the needs of the
developing world. Such activities may include--
(1) basic genomic research on crops grown in the developing
world;
(2) basic research in plant biotechnology that will advance
and expedite the development of improved cultivars, including
those that are pest-resistant, produce increased yield, reduce
the need for fertilizers, or increase tolerance to stress;
(3) basic research that could lead to the development of
technologies to produce pharmaceutical compounds such as
vaccines and medications in plants that can be grown in the
developing world; and
(4) research on the impact of plant biotechnology on the
social, political, economic, and environmental conditions in
countries in the developing world.
SEC. 5. AUTHORIZATION OF APPROPRIATIONS.
There are authorized to be appropriated to the National Science
Foundation $9,000,000 for fiscal year 2002, $13,500,000 for fiscal year
2003, and $13,500,000 for fiscal year 2004 to carry out this Act.
Passed the House of Representatives May 14, 2002.
Attest:
JEFF TRANDAHL,
Clerk.